161 related articles for article (PubMed ID: 33589102)
21. Stress Dose Steroids: Myths and Perioperative Medicine.
MacKenzie CR; Goodman SM
Curr Rheumatol Rep; 2016 Jul; 18(7):47. PubMed ID: 27351679
[TBL] [Abstract][Full Text] [Related]
22. Systemic rheumatic diseases: From biological agents to small molecules.
Sarzi-Puttini P; Ceribelli A; Marotto D; Batticciotto A; Atzeni F
Autoimmun Rev; 2019 Jun; 18(6):583-592. PubMed ID: 30959214
[TBL] [Abstract][Full Text] [Related]
23. Changing incidence of orthopedic surgery in rheumatic disease: contributing factors.
Bernstein EJ; Mandl LA
Curr Rheumatol Rep; 2013 Oct; 15(10):365. PubMed ID: 23955065
[TBL] [Abstract][Full Text] [Related]
24. [Lymphoma in rheumatic diseases].
Rubbert-Roth A; Bittenbring JT; Assmann G
Z Rheumatol; 2017 Oct; 76(Suppl 2):46-56. PubMed ID: 29330755
[TBL] [Abstract][Full Text] [Related]
25. The perioperative use of biologic agents in patients with rheumatoid arthritis.
Polachek A; Caspi D; Elkayam O
Autoimmun Rev; 2012 Dec; 12(2):164-8. PubMed ID: 22522087
[TBL] [Abstract][Full Text] [Related]
26. Total Joint Arthroplasty in Patients with Inflammatory Rheumatic Diseases.
Compagnoni R; Gualtierotti R; Randelli P
Adv Ther; 2018 Aug; 35(8):1133-1139. PubMed ID: 29995301
[TBL] [Abstract][Full Text] [Related]
27. The management of surgery and therapy for rheumatic disease.
Ronald MacKenzie C; Goodman SM; Miller AO
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):735-749. PubMed ID: 31427052
[TBL] [Abstract][Full Text] [Related]
28. Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs.
Scherrer CB; Mannion AF; Kyburz D; Vogt M; Kramers-de Quervain IA
Arthritis Care Res (Hoboken); 2013 Dec; 65(12):2032-40. PubMed ID: 23861140
[TBL] [Abstract][Full Text] [Related]
29. Perioperative management of biologic agents used in treatment of rheumatoid arthritis.
Mushtaq S; Goodman SM; Scanzello CR
Am J Ther; 2011 Sep; 18(5):426-34. PubMed ID: 20216205
[TBL] [Abstract][Full Text] [Related]
30. Medications in pregnancy and breastfeeding.
Tosounidou S; Gordon C
Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():68-76. PubMed ID: 32019728
[TBL] [Abstract][Full Text] [Related]
31. Elective surgery in rheumatic disease and immunosuppression: to pause or not.
Härle P; Straub RH; Fleck M
Rheumatology (Oxford); 2010 Oct; 49(10):1799-800. PubMed ID: 20219787
[No Abstract] [Full Text] [Related]
32. [Biologics and further new drugs for rheumatic diseases since 2000].
Krüger K
Orthopade; 2018 Nov; 47(11):906-911. PubMed ID: 30280235
[TBL] [Abstract][Full Text] [Related]
33. Rheumatoid arthritis: Perioperative management of biologics and DMARDs.
Goodman SM
Semin Arthritis Rheum; 2015 Jun; 44(6):627-32. PubMed ID: 25747348
[TBL] [Abstract][Full Text] [Related]
34. The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa I; Tanaka Y
Immunol Med; 2020 Sep; 43(3):98-102. PubMed ID: 32306849
[TBL] [Abstract][Full Text] [Related]
35. Lower extremity arthroplasty in patients with inflammatory arthritis: preoperative and perioperative management.
Goodman SM; Figgie M
J Am Acad Orthop Surg; 2013 Jun; 21(6):355-63. PubMed ID: 23728960
[TBL] [Abstract][Full Text] [Related]
36. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
Manolis AS; Tzioufas AG
Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
[TBL] [Abstract][Full Text] [Related]
37. [Cardiovascular disease in rheumatic diseases].
Nasonov EL; Popkova TV; Novikova DS
Ter Arkh; 2016; 88(5):4-12. PubMed ID: 27458622
[TBL] [Abstract][Full Text] [Related]
38. Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases.
Brites L; Madeira N; Rodrigues J; Marona J; Martins N; Águeda A; Freitas R; Neto A; Capela S; Sequeira G; Ganhão S; Duarte C; Santiago M; Santos MJ
Acta Reumatol Port; 2019; 44(4):266-272. PubMed ID: 32008032
[TBL] [Abstract][Full Text] [Related]
39. Perioperative management of patients with rheumatic diseases.
Bissar L; Almoallim H; Albazli K; Alotaibi M; Alwafi S
Open Rheumatol J; 2013; 7():42-50. PubMed ID: 24062860
[TBL] [Abstract][Full Text] [Related]
40. [Chinese expert-based consensus for methotrexate in rheumatic diseases].
Chinese Association of Rheumatology and Immunology Physicians
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
